APO RESEARCH · REPORT
Olanzapine
Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
Product & engineering
Understand the product.
Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
Selected research
Market Analysis & Forecast
Global Olanzapine Market Analysis and Forecast 2026-2032
Market perspective
Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
Global Olanzapine key players include Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Hansoh Pharmaceutical, etc. Global top five manufacturers hold a share over 85%.
North America is the largest market, with a share over 70%, followed by Asia, which has a share over 25%.
Read the full market overview
In terms of product, Patent is the largest segment, with a share about 55%. And in terms of application, the largest application is Olanzapine Tablets, followed by Daily Commodities, etc.
This report presents an overview of global market for Olanzapine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Olanzapine, also provides the sales of main regions and countries. Of the upcoming market potential for Olanzapine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Olanzapine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Olanzapine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Olanzapine sales, projected growth trends, production technology, application and end-user industry.
Olanzapine Segment by Company
Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Apotex Inc.
Mylan Pharmaceuticals
Par Pharmaceutical
Aurobindo Pharma
Torrent Pharmaceuticals
Jubilant Lifesciences
Sun Pharmaceutical
Sandoz
Hansoh Pharmaceutical
WATSON Pharmaceuticals(Changzhou)
Zhejiang Langhua Pharmaceuticals
Olanzapine Segment by Type
Patent
Generics
Olanzapine Segment by Application
Olanzapine Tablets
Others
Olanzapine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olanzapine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Olanzapine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olanzapine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Olanzapine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Olanzapine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Olanzapine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Patent
- Generics
Applications
- Olanzapine Tablets
- Others
Companies covered
- Lilly
- Teva Pharmaceutical
- Dr. Reddy's Laboratories
- Apotex Inc.
- Mylan Pharmaceuticals
- Par Pharmaceutical
- Aurobindo Pharma
- Torrent Pharmaceuticals
- Jubilant Lifesciences
- Sun Pharmaceutical
- Sandoz
- Hansoh Pharmaceutical
- WATSON Pharmaceuticals(Changzhou)
- Zhejiang Langhua Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Olanzapine Market by Type
- 1.2.1 Global Olanzapine Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Patent
- 1.2.3 Generics
- 1.3 Olanzapine Market by Application
- 1.3.1 Global Olanzapine Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Olanzapine Tablets
- 1.3.3 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Olanzapine Market Dynamics
- 2.1 Olanzapine Industry Trends
- 2.2 Olanzapine Industry Drivers
- 2.3 Olanzapine Industry Opportunities and Challenges
- 2.4 Olanzapine Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Olanzapine Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Olanzapine Revenue by Region
- 3.2.1 Global Olanzapine Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Olanzapine Revenue by Region (2021-2026)
- 3.2.3 Global Olanzapine Revenue by Region (2027-2032)
- 3.2.4 Global Olanzapine Revenue Market Share by Region (2021-2032)
- 3.3 Global Olanzapine Sales Estimates and Forecasts 2021-2032
- 3.4 Global Olanzapine Sales by Region
- 3.4.1 Global Olanzapine Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Olanzapine Sales by Region (2021-2026)
- 3.4.3 Global Olanzapine Sales by Region (2027-2032)
- 3.4.4 Global Olanzapine Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Olanzapine Revenue by Manufacturers
- 4.1.1 Global Olanzapine Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Olanzapine Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Olanzapine Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Olanzapine Sales by Manufacturers
- 4.2.1 Global Olanzapine Sales by Manufacturers (2021-2026)
- 4.2.2 Global Olanzapine Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Olanzapine Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Olanzapine Sales Price by Manufacturers (2021-2026)
- 4.4 Global Olanzapine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Olanzapine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Olanzapine Manufacturers, Product Type & Application
- 4.7 Global Olanzapine Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Olanzapine Market CR5 and HHI
- 4.8.2 2025 Olanzapine Tier 1, Tier 2, and Tier 3
5 Olanzapine Market by Type
- 5.1 Global Olanzapine Revenue by Type
- 5.1.1 Global Olanzapine Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Olanzapine Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Olanzapine Revenue Market Share by Type (2021-2032)
- 5.2 Global Olanzapine Sales by Type
- 5.2.1 Global Olanzapine Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Olanzapine Sales by Type (2021-2032) & (Kg)
- 5.2.3 Global Olanzapine Sales Market Share by Type (2021-2032)
- 5.3 Global Olanzapine Price by Type
6 Olanzapine Market by Application
- 6.1 Global Olanzapine Revenue by Application
- 6.1.1 Global Olanzapine Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Olanzapine Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Olanzapine Revenue Market Share by Application (2021-2032)
- 6.2 Global Olanzapine Sales by Application
- 6.2.1 Global Olanzapine Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Olanzapine Sales by Application (2021-2032) & (Kg)
- 6.2.3 Global Olanzapine Sales Market Share by Application (2021-2032)
- 6.3 Global Olanzapine Price by Application
7 Company Profiles
- 7.1 Lilly
- 7.1.1 Lilly Company Information
- 7.1.2 Lilly Business Overview
- 7.1.3 Lilly Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Lilly Olanzapine Product Portfolio
- 7.1.5 Lilly Recent Developments
- 7.2 Teva Pharmaceutical
- 7.2.1 Teva Pharmaceutical Company Information
- 7.2.2 Teva Pharmaceutical Business Overview
- 7.2.3 Teva Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Teva Pharmaceutical Olanzapine Product Portfolio
- 7.2.5 Teva Pharmaceutical Recent Developments
- 7.3 Dr. Reddy's Laboratories
- 7.3.1 Dr. Reddy's Laboratories Company Information
- 7.3.2 Dr. Reddy's Laboratories Business Overview
- 7.3.3 Dr. Reddy's Laboratories Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Dr. Reddy's Laboratories Olanzapine Product Portfolio
- 7.3.5 Dr. Reddy's Laboratories Recent Developments
- 7.4 Apotex Inc.
- 7.4.1 Apotex Inc. Company Information
- 7.4.2 Apotex Inc. Business Overview
- 7.4.3 Apotex Inc. Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Apotex Inc. Olanzapine Product Portfolio
- 7.4.5 Apotex Inc. Recent Developments
- 7.5 Mylan Pharmaceuticals
- 7.5.1 Mylan Pharmaceuticals Company Information
- 7.5.2 Mylan Pharmaceuticals Business Overview
- 7.5.3 Mylan Pharmaceuticals Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Mylan Pharmaceuticals Olanzapine Product Portfolio
- 7.5.5 Mylan Pharmaceuticals Recent Developments
- 7.6 Par Pharmaceutical
- 7.6.1 Par Pharmaceutical Company Information
- 7.6.2 Par Pharmaceutical Business Overview
- 7.6.3 Par Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Par Pharmaceutical Olanzapine Product Portfolio
- 7.6.5 Par Pharmaceutical Recent Developments
- 7.7 Aurobindo Pharma
- 7.7.1 Aurobindo Pharma Company Information
- 7.7.2 Aurobindo Pharma Business Overview
- 7.7.3 Aurobindo Pharma Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Aurobindo Pharma Olanzapine Product Portfolio
- 7.7.5 Aurobindo Pharma Recent Developments
- 7.8 Torrent Pharmaceuticals
- 7.8.1 Torrent Pharmaceuticals Company Information
- 7.8.2 Torrent Pharmaceuticals Business Overview
- 7.8.3 Torrent Pharmaceuticals Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Torrent Pharmaceuticals Olanzapine Product Portfolio
- 7.8.5 Torrent Pharmaceuticals Recent Developments
- 7.9 Jubilant Lifesciences
- 7.9.1 Jubilant Lifesciences Company Information
- 7.9.2 Jubilant Lifesciences Business Overview
- 7.9.3 Jubilant Lifesciences Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Jubilant Lifesciences Olanzapine Product Portfolio
- 7.9.5 Jubilant Lifesciences Recent Developments
- 7.10 Sun Pharmaceutical
- 7.10.1 Sun Pharmaceutical Company Information
- 7.10.2 Sun Pharmaceutical Business Overview
- 7.10.3 Sun Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Sun Pharmaceutical Olanzapine Product Portfolio
- 7.10.5 Sun Pharmaceutical Recent Developments
- 7.11 Sandoz
- 7.11.1 Sandoz Company Information
- 7.11.2 Sandoz Business Overview
- 7.11.3 Sandoz Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Sandoz Olanzapine Product Portfolio
- 7.11.5 Sandoz Recent Developments
- 7.12 Hansoh Pharmaceutical
- 7.12.1 Hansoh Pharmaceutical Company Information
- 7.12.2 Hansoh Pharmaceutical Business Overview
- 7.12.3 Hansoh Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Hansoh Pharmaceutical Olanzapine Product Portfolio
- 7.12.5 Hansoh Pharmaceutical Recent Developments
- 7.13 WATSON Pharmaceuticals(Changzhou)
- 7.13.1 WATSON Pharmaceuticals(Changzhou) Company Information
- 7.13.2 WATSON Pharmaceuticals(Changzhou) Business Overview
- 7.13.3 WATSON Pharmaceuticals(Changzhou) Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 WATSON Pharmaceuticals(Changzhou) Olanzapine Product Portfolio
- 7.13.5 WATSON Pharmaceuticals(Changzhou) Recent Developments
- 7.14 Zhejiang Langhua Pharmaceuticals
- 7.14.1 Zhejiang Langhua Pharmaceuticals Company Information
- 7.14.2 Zhejiang Langhua Pharmaceuticals Business Overview
- 7.14.3 Zhejiang Langhua Pharmaceuticals Olanzapine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Zhejiang Langhua Pharmaceuticals Olanzapine Product Portfolio
- 7.14.5 Zhejiang Langhua Pharmaceuticals Recent Developments
8 North America
- 8.1 North America Olanzapine Market Size by Type
- 8.1.1 North America Olanzapine Revenue by Type (2021-2032)
- 8.1.2 North America Olanzapine Sales by Type (2021-2032)
- 8.1.3 North America Olanzapine Price by Type (2021-2032)
- 8.2 North America Olanzapine Market Size by Application
- 8.2.1 North America Olanzapine Revenue by Application (2021-2032)
- 8.2.2 North America Olanzapine Sales by Application (2021-2032)
- 8.2.3 North America Olanzapine Price by Application (2021-2032)
- 8.3 North America Olanzapine Market Size by Country
- 8.3.1 North America Olanzapine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Olanzapine Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Olanzapine Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Olanzapine Market Size by Type
- 9.1.1 Europe Olanzapine Revenue by Type (2021-2032)
- 9.1.2 Europe Olanzapine Sales by Type (2021-2032)
- 9.1.3 Europe Olanzapine Price by Type (2021-2032)
- 9.2 Europe Olanzapine Market Size by Application
- 9.2.1 Europe Olanzapine Revenue by Application (2021-2032)
- 9.2.2 Europe Olanzapine Sales by Application (2021-2032)
- 9.2.3 Europe Olanzapine Price by Application (2021-2032)
- 9.3 Europe Olanzapine Market Size by Country
- 9.3.1 Europe Olanzapine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Olanzapine Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Olanzapine Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Olanzapine Market Size by Type
- 10.1.1 China Olanzapine Revenue by Type (2021-2032)
- 10.1.2 China Olanzapine Sales by Type (2021-2032)
- 10.1.3 China Olanzapine Price by Type (2021-2032)
- 10.2 China Olanzapine Market Size by Application
- 10.2.1 China Olanzapine Revenue by Application (2021-2032)
- 10.2.2 China Olanzapine Sales by Application (2021-2032)
- 10.2.3 China Olanzapine Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Olanzapine Market Size by Type
- 11.1.1 Asia Olanzapine Revenue by Type (2021-2032)
- 11.1.2 Asia Olanzapine Sales by Type (2021-2032)
- 11.1.3 Asia Olanzapine Price by Type (2021-2032)
- 11.2 Asia Olanzapine Market Size by Application
- 11.2.1 Asia Olanzapine Revenue by Application (2021-2032)
- 11.2.2 Asia Olanzapine Sales by Application (2021-2032)
- 11.2.3 Asia Olanzapine Price by Application (2021-2032)
- 11.3 Asia Olanzapine Market Size by Country
- 11.3.1 Asia Olanzapine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Olanzapine Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Olanzapine Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Olanzapine Market Size by Type
- 12.1.1 SAMEA Olanzapine Revenue by Type (2021-2032)
- 12.1.2 SAMEA Olanzapine Sales by Type (2021-2032)
- 12.1.3 SAMEA Olanzapine Price by Type (2021-2032)
- 12.2 SAMEA Olanzapine Market Size by Application
- 12.2.1 SAMEA Olanzapine Revenue by Application (2021-2032)
- 12.2.2 SAMEA Olanzapine Sales by Application (2021-2032)
- 12.2.3 SAMEA Olanzapine Price by Application (2021-2032)
- 12.3 SAMEA Olanzapine Market Size by Country
- 12.3.1 SAMEA Olanzapine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Olanzapine Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Olanzapine Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Olanzapine Value Chain Analysis
- 13.1.1 Olanzapine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Olanzapine Production Mode & Process
- 13.2 Olanzapine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Olanzapine Distributors
- 13.2.3 Olanzapine Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst